ctrl K

Relay Therapeutics Inc. (RLAY)

NASDAQ: RLAY · Real-Time Price · USD

3.31

-0.02 (-0.60%)

At close: May 01, 2025, 3:59 PM

3.40

2.87%

Pre-market: May 02, 2025, 08:14 AM EDT

Relay Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	10.01M	25.55M	1.38M	3.03M	82.65M	n/a	n/a
Cost of Revenue	5.46M	5.27M	4.13M	3.92M	3.55M	2.85M	2.15M
Gross Profit	4.54M	20.28M	-2.75M	-896K	79.11M	-2.85M	-2.15M
Operating Income	-372.47M	-373M	-299.27M	-364.7M	-55.8M	-84.05M	-49.89M
Interest Income	34.75M	31.05M	8.79M	830K	3.4M	8.8M	1.11M
Pretax Income	-337.71M	-341.97M	-290.51M	-363.87M	-52.41M	-75.31M	-48.78M
Net Income	-337.71M	-341.97M	-254.26M	-496.81M	-49.01M	-66.5M	-48.78M
Selling & General & Admin	76.59M	74.95M	65.98M	57.39M	38.59M	13.74M	8.86M
Research & Development	319.09M	330.02M	246.35M	172.65M	99.86M	70.31M	41.03M
Other Expenses	-13.21M	n/a	-20K	-4K	-16K	-58K	-9K
Operating Expenses	382.48M	398.55M	312.33M	230.04M	138.45M	84.05M	49.89M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	382.48M	398.55M	312.33M	230.04M	138.45M	84.05M	49.89M
Income Tax Expense	n/a	n/a	-36.25M	132.94M	-3.4M	-8.8M	1.1M
Shares Outstanding (Basic)	142.87M	122.58M	112.23M	95.14M	42.62M	4.28M	2.49M
Shares Outstanding (Diluted)	142.87M	122.58M	112.23M	95.14M	42.62M	4.28M	2.49M
EPS (Basic)	-2.36	-2.79	-2.27	-5.22	-1.15	-15.53	-19.63
EPS (Diluted)	-2.36	-2.79	-2.27	-5.22	-1.15	-15.53	-19.63
EBITDA	-372.47M	-374.15M	-306.82M	-222.18M	-52.25M	-81.2M	-47.73M
EBIT	-385.67M	-379.42M	-310.95M	-227.01M	-55.8M	-84.05M	-48.78M
Depreciation & Amortization	5.46M	5.27M	4.13M	3.92M	3.55M	2.85M	2.15M